Company Information
CIN
Status
Date of Incorporation
13 July 1961
State / ROC
Mumbai / ROC Mumbai
Last Balance Sheet
31 March 2023
Last Annual Meeting
30 September 2023
Paid Up Capital
2,824,180
Authorised Capital
220,000,000
Directors
Ajit Daljit Singh
Director/Designated Partner
over 2 years ago
over 2 years ago
Karan Jasjit Singh
Director/Designated Partner
over 2 years ago
over 2 years ago
Jasjit Daljit Singh
Director/Designated Partner
over 5 years ago
over 5 years ago
Selwyn Mariano Jonas Noronha
Director/Designated Partner
about 10 years ago
about 10 years ago
Past Directors
Jagmohanlal Chopra
Additional Director
about 19 years ago
about 19 years ago
Patents
The present disclosure pertains to the field of solid pellet formulations, in particular, formulations of hyaluronic acid in pellet form. The hyaluronic acid formulation comprises non-pareil seed in an amount in the range of 33 to 50 % w/w, hyaluronic acid in an amount in the range of 28 to 42 % w/w, at least one ad...
The present invention provides astable hard capsule shell comprising starch and pullulan wherein wherein the capsule shell exhibits enhanced dimensional stability as compared to capsule shell comprising pullulan alone, when exposed to high relative humidity.
A process for preparing HPMC based hard capsule shells that exhibit enhanced transparency in transparent capsules and enhanced whiteness in opaque capsules. The process comprises the preparation of low molecular weight HPMC solution in acidic medium/condition maintaining a pH of about 3 to about 5 and subsequent man...
The present disclosure pertains to the field of capsules, in particularly, to odour
masking capsule banding composition. The present invention discloses an odour
masking capsule banding composition. The composition comprises at least one
10 odor-masking agent in an amount in the range of 0.2-25% by weight based o...
The present disclosure pertains to the field of an oral delivery system for delivering medication and/or ingredients to a part of a gastrointestinal tract. The invention also relates to a process for preparing the delivery system.
This invention relates to a delivery system for delivering medication or ingredient...
The present disclosure pertains to the field of microparticulate dry powder compositions, in particular, compositions conferring protection against tuberculosis and more particularly to a composition formulated for pulmonary delivery. The present invention envisages a microparticulate dry powder composition, optimiz...
The present disclosure pertains to the field of capsules and method for making the same. More particularly, present invention relates to a composition for enteric capsules and method for preparation thereof. The enteric capsules of the present disclosure, have capsule body and cap portions formed by dip-molding usin...
The present disclosure pertains to the field of capsules and method for making the same. More particularly, present disclosure relates to a composition for acid resistant capsules and method for preparation thereof. The delayed release capsules of the present disclosure, have capsule body and cap portions formed by ...
The present invention relates to the tabsule dosage form with a new design of the tablet core encompassing the step. This in turn ensures the precise gap for tabsules to ensure the defined dissolution. The invention also relates to methods for manufacturing such step incorporated in the tabsule dosage form.
...
Registered Trademarks
[Class : 7] Capsule Filling Machines; Capsule Packing And Labelling Machines; Machines, Tools, Power Operated Tools; Blister Packing Machines; Cortoning Machines; Softgel And Hard Gel Encapsulation Machine; Belts For Conveyors; Belts For Machines; Cartoning Machines, Case Packers, Stretch Banders, Tube Filling And Bottling Equipment; Labelling Machines; Etc.
[Class : 16] Paper And Cardboard For Packaging Of Pharmaceuticals; Printed Matter; Plastic Sheets, Films And Bags For Wrapping And Packaging; Packaging Materials Namely Cartons, Films, Boxes, Barrier Packaging Films And Foils; Carrier Bags Of Paper Or Plastic; Padding Materials Of Paper Or Cardboard, Stuffing Of Paper Or Cardboard; Paper Bags For Use In Sterilization; Wrappi...
[Class : 5] Capsules For Medicines And Pharmaceuticals; Hard Gel, Soft Gel Capsules; Pharmaceutical, Biological, Medical, And Veterinary Preparations; Anti Inflammatories; Antibiotics; Antiseptics; Medicines And Pharmaceuticals For Human And Veterinary Purposes; Etc.
View +40 more Brands for Acg Associated Capsules Private Limited.
Charges
21 April 2014
The Hongkong And Shanghai Banking Corporation Limited
588 Crore
29 December 2011
Standard Chartered Bank
97 Crore
24 May 1999
Standard Chartered Bank (acting As Lead Bank For Itself And On Behalf Of Sbi & Citi Bank)
42 Crore
10 April 1997
Standard Chartered Bank (acting As Lead Bank For Itself And On Behalf Of Sbi & Citi Bank)
42 Crore
27 March 1997
Industrial Development Bank Of India
7 Crore
12 September 1994
The Industrial Credit And Investment Corpn. Of India Ltd.
7 Crore
23 February 1994
Industrial Development Bank Of India
3 Crore
20 October 1992
Industrial Development Bank Of India
1 Crore
29 March 1984
Anz Grindlays Bank Ltd.
1 Crore
04 March 1965
Bank Of Maharashtra
2 Lak
29 June 2007
Icici Bank Limited
13 Crore
28 June 2022
Citi Bank N.a.
0
21 April 2014
The Hongkong And Shanghai Banking Corporation Limited
0
24 May 1999
Standard Chartered Bank (acting As Lead Bank For Itself And On Behalf Of Sbi & Citi Bank)
0
04 March 1965
Bank Of Maharashtra
0
20 October 1992
Industrial Development Bank Of India
0
23 February 1994
Industrial Development Bank Of India
0
29 December 2011
Standard Chartered Bank
0
29 June 2007
Icici Bank Limited
0
29 March 1984
Anz Grindlays Bank Ltd.
0
27 March 1997
Industrial Development Bank Of India
0
10 April 1997
Standard Chartered Bank (acting As Lead Bank For Itself And On Behalf Of Sbi & Citi Bank)
0
12 September 1994
The Industrial Credit And Investment Corpn. Of India Ltd.
0
28 June 2022
Citi Bank N.a.
0
21 April 2014
The Hongkong And Shanghai Banking Corporation Limited
0
24 May 1999
Standard Chartered Bank (acting As Lead Bank For Itself And On Behalf Of Sbi & Citi Bank)
0
04 March 1965
Bank Of Maharashtra
0
20 October 1992
Industrial Development Bank Of India
0
23 February 1994
Industrial Development Bank Of India
0
29 December 2011
Standard Chartered Bank
0
29 June 2007
Icici Bank Limited
0
29 March 1984
Anz Grindlays Bank Ltd.
0
27 March 1997
Industrial Development Bank Of India
0
10 April 1997
Standard Chartered Bank (acting As Lead Bank For Itself And On Behalf Of Sbi & Citi Bank)
0
12 September 1994
The Industrial Credit And Investment Corpn. Of India Ltd.
0
28 June 2022
Citi Bank N.a.
0
21 April 2014
The Hongkong And Shanghai Banking Corporation Limited
0
24 May 1999
Standard Chartered Bank (acting As Lead Bank For Itself And On Behalf Of Sbi & Citi Bank)
0
04 March 1965
Bank Of Maharashtra
0
20 October 1992
Industrial Development Bank Of India
0
23 February 1994
Industrial Development Bank Of India
0
29 December 2011
Standard Chartered Bank
0
29 June 2007
Icici Bank Limited
0
29 March 1984
Anz Grindlays Bank Ltd.
0
27 March 1997
Industrial Development Bank Of India
0
10 April 1997
Standard Chartered Bank (acting As Lead Bank For Itself And On Behalf Of Sbi & Citi Bank)
0
12 September 1994
The Industrial Credit And Investment Corpn. Of India Ltd.
0
Documents
Form MSME FORM I-24042024_signed
Form Addendum to AOC-4 CSR-29032024
Form MGT-7-09012024_signed
Form AOC-4(XBRL)-08122023_signed
Optional Attachment-(1)-28112023
List of share holders, debenture holders;-28112023
Copy of MGT-8-28112023
Form MGT-7-28112023
Form MSME FORM I-18112023_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-30102023
XBRL document in respect Consolidated financial statement-30102023
Form AOC-4(XBRL)-30102023
Form MSME FORM I-27102023
Form MGT-7-08102023_signed
Form MGT-7-10102023_signed
Form Addendum to AOC-4 CSR-02092023_signed
Form MSME FORM I-29082023_signed
Form Addendum to AOC-4 CSR-31032023
Form MSME FORM I-28042023_signed
XBRL document in respect Consolidated financial statement-01032023
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-01032023
Form AOC-4(XBRL)-01032023_signed
Form ADT-1-07022023_signed
Copy of written consent given by auditor-07022023
Copy of the intimation sent by company-07022023
Optional Attachment-(2)-07022023
Copy of resolution passed by the company-07022023
List of share holders, debenture holders;-30112022
Copy of MGT-8-30112022
Optional Attachment-(1)-30112022
